PILGRIM CONCORD JOINT SYMPOSIUM

Similar documents
NEWSLETTER 1 MARCH Produced by CSO-MOH IL

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

LA-MRSA in the Netherlands: the past, presence and future.

EFSA s activities on Antimicrobial Resistance

Assembly Hall/Festival Hall, University of Bonn, Germany

Med-Vet-Net Association: embracing one health Anne Ridley MVNA Project Manager AHVLA, Weybridge

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

LA-MRSA in Norway. One Health Seminar 27 June 2017, Ålesund

Seminar on communicable diseases prevention and control

Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector

EU Research on Antimicrobial drug resistance Anna Lönnroth Sjödén Unit Infectious Diseases, Directorate Health DG Research European Commission

EU strategy to fight against Antimicrobial Resistance

Council of the European Union Brussels, 13 June 2016 (OR. en)

GLOBAL CONFERENCE Global elimination of dog-mediated human rabies The Time Is Now

Table Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8

MRSA control strategies in Europekeeping up with epidemiology?

Stratégie et action européennes

Evaluation of EU strategy to combat AMR

COMMISSION OF THE EUROPEAN COMMUNITIES

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/

The European AMR Challenge - strategic views from the human perspective -

European Medicines Agency role and experience on antimicrobial resistance

WHO global and regional activities on AMR and collaboration with partner organisations

MRSA found in British pig meat


Global Conference on Rabies Control: Towards Sustainable Prevention at the Source

12 th Biennial STVM Conference 2014

Promoting One Health : the international perspective OIE

OIE Reference Laboratory Reports Activities

ANTIBIOTICS AND ANTIMICROBIAL RESISTANCE: CAUSES AND POSSIBLE SOLUTIONS

OIE Collaborating Centres Reports Activities

Antibiotic stewardship Implementing Strategies

OECD WORK ON AMR: TACKLING THE NEGATIVE CONSEQUENCES OF ANTIBIOTIC RESISTANCE ON HUMAN HEALTH. Michele Cecchini OECD Health Division

Actions for combatting Antimicrobial Resistance (AMR)

Annual report of the Scientific Network on BSE-TSE 2015

OIE Strategy on Antimicrobial Resistance and the need for new diagnostic tools

W O s trategi g c i actio i n o n pl p a l n n on o ant n ib i i b o i t o ic i resis i tanc n e in i n Eu E r u op o e p

World Health Organization Emerging and other Communicable Diseases, Surveillance and Control

Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana

MRSA in the United Kingdom status quo and future developments

Postgraduate Technical Workshop Laboratory Diagnosis of Human Parasitic Infections

Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013

OIE capacity-building activities

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting

OIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)

All participants at the Salt Lake City confirmed strong support for the OIE assuming an international laboratory animal welfare role.

What is the problem? Latest data on antibiotic resistance

WORKSHOP AGENDA. Coordinated Research Initiative for the Implementation of Antimicrobial Resistance Control Strategies (CTI A (SCSC))

EU Health Priorities. Jurate Svarcaite Secretary General PGEU

OIE Platform on Animal Welfare for Europe

2017 EU Action Plan against AMR state of play of implementation One-Health Network on AMR 26 October Brussels

Australia s response to the threat of antimicrobial resistance

Infection control in Indonesian hospitals

Antibiotic resistance: the rise of the superbugs

OIE Reference Laboratory Reports Activities

The European road map against antimicrobial resistance

Prof. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons

SCIENTIFIC REPORT OF EFSA

Absence of LA-MRSA CC398 as nasal colonizer of pigs raised

Second Meeting of the Regional Steering Committee of the GF-TADs for Europe. OIE Headquarters, Paris, 18 December 2007.

OIE Standards for: Animal identification and traceability Antimicrobials

Table Of Content. D Final Report 'Primary Care Anti-infective agent prescribing for Common

OIE Collaborating Centres Reports Activities

German Antimicrobial Resistance Strategy DART 2020

WORLD ORGANIZATION FOR ANIMAL HEALTH /OIE/- ENGAGEMENT WITH ANIMAL WELFARE AND THE VETERINARY PROFFESSION

The Commission activities on AMR (focus on zoonotic issues)

EFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA

Antimicrobial resistance (EARS-Net)

Aabo, Søren; Ricci, Antonia; Denis, Martine; Bengtsson, Björn; Dalsgaard, Anders; Rychlik, Ivan; Jensen, Annette Nygaard

Consumption of antibiotics in hospitals. Antimicrobial stewardship.

Persistence of livestock-associated MRSA after short term occupational exposure to

Prevention and control of Campylobacter in the poultry production system

Assembly Hall/Festival Hall, University of Bonn, Germany

Campylobacter infections in EU/EEA and related AMR

Antimicrobial Resistance, yes we care! The European Joint Action

Update on European Agencies activities in the field of AMR

International Conference on University College Cork, Ireland. 5 th - 6 th September 2017

The challenge of growing resistance

9: Coffee Break. 10:00-11: Spatial Risk Mapping (Thomas Van Boekel) 11:00-12: Dynamic Bayesian Network (Yrjo Grohn)

Joint scientific report of ECDC, EFSA and EMEA on meticillin resistant Staphylococcus aureus (MRSA) in livestock, companion animals and food 1.

Antibiotics and resistance in the WHO Regional Office for Europe. Dr Nienke van de Sande On behalf of the AMR Working Group

WHY STAKEHOLDER ENGAGEMENT IS CRITICAL TO OIE STRAY DOG INITIATIVE

Exemplary Project. I-4-1-HEALTH - INTERREG April 2018

AMR situation in Europe: Strategy and vision

OIE activities related to wildlife and biodiversity

Fourth OIE Global Conference on Animal Welfare Animal welfare for a better world. Opening Session

Zoonoses in food and feed

Role of the expanded OIE Collaborating Centre for Food Safety

Quelle politique antibiotique pour l Europe? Dominique L. Monnet

Unfair competition practices the impact on professional breeders and traders

ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU

FVE and responsible use of antimicrobials

Petya Petkova and Alexandra Hammond- Seaman

ASSEMBLY HALL/FESTIVAL HALL, UNIVERSITY OF BONN, GERMANY

Antimicrobial Resistance Initiative

MRSA Control : Belgian policy

Contents & results of 3 years of VMP FP training Susanne Münstermann OIE Scientific and Technical Department

OIE strategy on AMR and the Prudent Use of Antimicrobials

EU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play

Summary of the latest data on antibiotic resistance in the European Union

Transcription:

Two EU funded projects present... ff research results ff practical recommendations...in the fight against MRSA BRUSSELS 28-29 November 2011

Welcome We kindly invite you to the PILGRIM - CONCORD Joint Symposium to obtain the latest information on current research on MRSA and its impact on society, animal production and public health. Invited keynote speakers from a wide variety of stakeholder groups will share their expertise, experience and views with you. A warm welcome to the PILGRIM - CONCORD Joint Symposium Prof Katharina Stärk, PILGRIM Coordinator, Professor of Veterinary Public Health, The Royal Veterinary College London (RVC) Prof Ad Fluit, CONCORD Coordinator, Associate Professor, University Medical Center Utrecht 1

Introduction On day one, we would like to introduce you to our MRSA-related research activities by presenting our latest results on MRSA epidemiology, generated in the PILGRIM and CONCORD projects. On day two, we will focus on the research in diagnostic molecular tools, modelling and fundamental research and colonisation as well as host specificity. These topics will be followed by presentations demonstrating the practical outcome from both projects and development of suitable interventions against MRSA. A press conference and presentations of key stakeholders from both animal and healthcare settings, as well as policy-makers and industrial and international organisations will present different perspectives on MRSA-related problems. Several organisations and projects related to MRSA will display their activities parallel to the official programme. This will provide a unique opportunity to all participants for further discussion, exchange and collaboration. PROGRAMME Day 1: Monday, 28 November 2011 Registration, 13:00 Opening 13:30 MRSA media scare or true risk, Katharina Stärk / Ad Fluit 13:45 EFSA s activities supporting the EU strategy on AMR, Marta Hugas MRSA - State-of-the-art 14:15 The history of MRSA until 2007 including CA-MRSA, Robert Skov 14:45 LA-MRSA: Just another S. aureus for animals, Jaap Wagenaar 15:15 Coffee break Epidemiology 15:45 The spread of LA-MRSA among animals and humans, Els Broens / Brigitte van Cleef 16:15 Population Structure of CA-MRSA and LA-MRSA in Europe, Herminia de Lencastre / Lina Cavaco 16:45 Pig trade and antibiotic use as possible factors enhancing the spread of LA-MRSA in pig production, Luca Guardabassi 17:15 End of day 1 2

Day 2: Tuesday, 29 November 2011 Welcome coffee, 8:30 PILGRIM CONCORD Diagnostic molecular tools 09:00 Microarrays and PCR understanding host-pathogen interaction and development of rapid diagnostics, Jodi Lindsay / Floyd Wittink Modelling 09:30 Nosocomial transmission of Community-associated Methicillin-resistant Staphylococcus aureus, David Hetem 10:00 Modelling the spread of LA-MRSA: Who will catch it and where? Mariano Ciccolini / Katharina Stärk / Thibaud Porphyre 10:30 Coffee break Fundamental research 10:45 Community- and Livestock-associated MRSA from a whole genome perspective, Ad Fluit 11:15 Transcriptome analysis of CA/FA-MRSA isolates, Nicole ten Broeke-Smits / Floyd Wittink 11:45 Virulence factors from CA- and LA-MRSA, Gerard Lina / Sergey Konstantinov 12:15 Resistance genes in LA-MRSA, Frank M. Aarestrup / Jesper Larsen 12:45 Lunch / Colonisation and host specificity 13:30 Studies in vivo of acquisition and persistence of colonisation of pigs with MRSA, David Lloyd 14:00 A human colonization study with ST398, Bibi Slingerland / Willem van Wamel 14:30 In vitro and in vivo experiments on S. aureus host specificity, Arshnee Moodley Interventions 12:45 MRSA press conference 15:00 Bacteriophage control of MRSA in pigs on the farm, Birgitta Duim / John Hardcastle 15:30 Development and validation of a technology testing platform for MRSA decontamination, Stathis Giotis 16:00 Coffee break Impact and conclusions by stakeholders 16:15 Consortia recommendations 16:25 MRSA position of European veterinarians, Jan Bernardy 16:40 Political consequences. Examples from the EurSafety project, Alex Friedrich 16:55 Future research needs, Marc Bonten 17:10 Opportunities for industry, tbd 17:25 EU policy and support, Anna Lönnroth 3

Speakers and Chairs PILGRIM The EU funded project PILGRIM has investigated MRSA for nearly three years. Its partners will present their research results and practical recommendations concerning MRSA in livestock and in the public health sector. Prof Katharina Stärk, The Royal Veterinary College, London, United Kingdom Dr Robert Skov, Statens Serum Institute, Copenhagen, Denmark Dr Jodi Lindsay, Centre for Infection Cellular and Molecular Medicine, St George s University of London, United Kingdom Dr Jesper Larsen, Statens Serum Institute, Copenhagen, Denmark Prof Andreas Voss, Radboud University Nijmegen Medical Center, Nijmegen, Dr Els Broens, National Institute Public Health and the Environment, Bilthoven, Dr Brigitte van Cleef, National Institute Public Health and the Environment, Bilthoven, Prof Luca Guardabassi, Kobenhavns Universitet, Copenhagen, Denmark Prof David Lloyd, The Royal Veterinary College, University of London, United Kingdom Dr Willem van Wamel, Erasmus University Medical Center, Rotterdam, Ms Bibi Slingerland, Erasmus University Medical Center, Rotterdam, Dr Arshnee Moodley, Department of Veterinary Disease, University of Copenhagen, Denmark Prof Patrick Butaye, Veterinary and Agrochemical Research Centre, VAR-CODA-CERVA, Brussels, Belgium Dr Efstathios Giotis, The Royal Veterinary College, London, United Kingdom 4

CONCORD The EU funded project CONCORD has explored the adaptation of MRSA to the community and farms. Project participants present their results on fundamental research, experiments and mathematical modelling as well as effective strategies against CA- and FA-MRSA. Prof Ad Fluit, University Medical Center Utrecht, Dr Jaap Wagenaar, University Utrecht, Dr Lina Cavaco, National Food Institute, Technical University of Denmark, Lyngby, Denmark Dr Herminia de Lencastre, Instituto de Tecnologia Quimica e Biologica (ITQB), Oeiras, Portugal Dr Floyd Wittink, University of Amsterdam, Nicole ten Broeke-Smits, University Medical Center Utrecht, Dr Gerard Lina, Laboratoire de Bacteriologie, Université de Lyon, France Dr Sergey Konstantinov, University Medical Center Utrecht, Prof Frank M. Aarestrup, National Food Institute, Technical University of Denmark, Lyngby, Denmark Dr Birgitta Duim, University Utrecht, Dr David Hetem, University Medical Center Utrecht, John Hardcastle, Novolytics Limited, Warrington, United Kingdom Dr Mariano Ciccolini, Centre for Infectious Diseases, University of Edinburgh, United Kingdom Key note speakers Prof Alex Friedrich, Lead Partner of EurSafety Health-Net, Universitair Medisch Centrum Groningen, Prof Jan Bernardy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic Prof Marc Bonten, Professor of Molecular Epidemiology of Infectious Diseases, University Medical Center Utrecht, 5 Dr Anna Lönnroth, European Commission, Research DG, Health Research, Infectious Diseases, Brussels, Belgium Dr Marta Hugas, Head of Unit of Biological Hazards, European Food Safety Authority (EFSA), Parma, Italy

Location The PILGRIM - CONCORD Joint Symposium takes place at the Auditorium The Arc of the meeting centre SQUARE in Brussels. SQUARE - Brussels Meeting Centre Glass Entrance rue Mont des Arts B-1000 Brussels www.square-brussels.com Directions SQUARE is located close to Brussels Central railway station. Inside the station, there are exit signs to Mont des Arts SQUARE. International trains arrive at Brussels Midi. From there, it is a two-minute train journey to Brussels Central. There are direct trains from Brussels International Airport (Zaventem) to Brussels Central. The train journey takes 17 minutes. For more detailed directions please visit www.square-brussels.com Accommodation Accommodation needs to be arranged by participants individually. You can find several hotels close to the SQUARE, e.g. on www.booking.com Date Monday, 28 November, 13:00-17:30 h Tuesday, 29 November, 09:00-18:00 h More information is available on www.fp7-pilgrim.eu/event 6

Organisation This event is organised by partners of the PILGRIM and CONCORD projects. Registration Please register online on www.fp7-pilgrim.eu/event/registration until 30 September 2011. Participation in the PILGRIM - CONCORD Joint Symposium is free. Places are limited. Contact For questions regarding local facilities (SQUARE), please contact: Dr Cristina Garcia-Graells Université Libre de Bruxelles-Hôpital Erasme Brussels, Belgium cgarciag@ulb.ac.be For organisational questions, please contact: Mr Michael Messerli accelopment AG, Switzerland mmesserli@accelopment.com 7